Metastatic breast cancer cells inhibit osteoblast differentiation through the Runx2/CBFbdependent expression of the Wnt antagonist, sclerostin.

Bibliographic Details
Published in:Breast Cancer Research Vol. 13; no. 4; pp. 3048 - 3062
Format: Journal Article
Published: BioMed Central 2011
Online Access:View this record in EBSCOhost